MetaCap

Syndax Pharmaceuticals Statistics

NASDAQ: SNDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.72-0.41 (-4.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Syndax Pharmaceuticals by the numbers

Syndax Pharmaceuticals has a market capitalization of $785.0 million based on 90.03M shares outstanding. With trailing EPS of $-2.37, Syndax Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.7% below its 50-day average and 55.1% below its 200-day average.

Average daily trading volume is 2.63M shares, or about $22.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SNDX valuation vs. peer median

SNDX compared with the median of 8 peer companies
MetricSNDXPeer medianDifference
Market cap$785.05M$773.14M+2%
Avg. volume2.63M1.32M+99%

Peer median across 8 companies: IRWD, VSTM, COLL, ORIC, RIGL, CRVS, PHAR, ARDX.

Valuation

Market cap
$785.05M
Price / sales (latest FY)
4.55
EPS (TTM)
$-2.37

Price and trading

Previous close
9.13
Open
9.14
Day range
8.69 – 9.27
52-week range
8.41 – 25.59
52-week change
-50.00%
Beta
—
Volume
2.18M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
785.05M
Forward Pe
-11.14
Eps
-2.37
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
25.59
Week52 Low
8.41
Avg Volume
2.63M
Shares Outstanding
90.03M
Ma50
14.22
Ma200
19.43
Earnings Date
Nov 2, 2026
Pct From52w High
-65.92%
Pct From52w Low
3.69%

Related